Gilead Gets 2 NuCana 'Anti-Cancer' Patents Nixed
Biotech giant Gilead Sciences Inc. convinced a London court on Tuesday to revoke two patents tied to potential cancer treatments belonging to British rival NuCana PLC after concluding that the treatments...To view the full article, register now.
Already a subscriber? Click here to view full article